171 related articles for article (PubMed ID: 2190395)
21. Allogeneic bone marrow transplantation for leukaemia and aplastic anaemia. Results of the Leipzig BMT Group.
Helbig W; Kubel M; Schwenke H; Thierbach V; Hoffmann FA; Standke E; Feyer P; Haustein B; Pönisch W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):383-7. PubMed ID: 2480278
[TBL] [Abstract][Full Text] [Related]
22. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
Britton K; Atkinson K; Downs K; Biggs J
Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
[No Abstract] [Full Text] [Related]
23. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation for pediatric patients with severe aplastic anemia in Taiwan.
Lin KH; Chen RL; Lin DT; Lui LT; Lin KS
Transplant Proc; 1993 Aug; 25(4 Suppl 3):61-4. PubMed ID: 8351722
[No Abstract] [Full Text] [Related]
25. Long-term follow-up of patients who received transplants for aplastic anemia or leukemia.
Gluckman E; Devergie A; Meletis J; De Castro H; Lehn P; Bourrhis JH; Keable H; Cavazzana M; Varrin F; Bombail D
Transplant Proc; 1987 Feb; 19(1 Pt 3):2643. PubMed ID: 3274572
[No Abstract] [Full Text] [Related]
26. Results of four different protocols for prophylaxis against graft-versus-host disease.
Tollemar J; Ringdén O; Bäckman L; Janossy G; Lönnqvist B; Markling L; Philstedt P; Sundberg B
Transplant Proc; 1989 Feb; 21(1 Pt 3):3008-10. PubMed ID: 2650414
[No Abstract] [Full Text] [Related]
27. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry.
Bortin MM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2655-7. PubMed ID: 3274576
[No Abstract] [Full Text] [Related]
28. Cyclosporine-A as prevention for graft-versus-host disease in pediatric patients undergoing bone marrow transplants.
Truog AW; Wozniak SP
Oncol Nurs Forum; 1990; 17(1):39-44. PubMed ID: 2405360
[TBL] [Abstract][Full Text] [Related]
29. Steady-state concentrations of cyclosporine for therapeutic monitoring.
Grevel J; Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
[No Abstract] [Full Text] [Related]
30. Regeneration of lymphocyte subpopulations after bone marrow transplantation: a study with monoclonal antibodies of the BL-series.
Pönisch W; Leiblein S; Friedrich T; Schwenke H; Helbig W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):527-30. PubMed ID: 2480302
[No Abstract] [Full Text] [Related]
31. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
Berenson RJ
Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
[No Abstract] [Full Text] [Related]
32. Evaluation of renal function in patients treated with bone marrow transplantation.
Stavljenić A; Cvorisćec D; Plavsić F; Bogdanić V; Labar B
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():112-3. PubMed ID: 2627598
[No Abstract] [Full Text] [Related]
33. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Marusić M; Francetić I; Kastelan A
Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
35. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a sheep polyclonal antibody: II. Evaluation of the whole blood methodology and comparison with an 3H tracer-mediated radioimmunoassay with a sheep polyclonal antibody.
Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1181-5. PubMed ID: 2190378
[No Abstract] [Full Text] [Related]
36. Allogeneic bone marrow transplantation using unrelated marrow donors.
Fay JW; Collins RH; Piñeiro L
Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
[No Abstract] [Full Text] [Related]
37. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM
Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417
[TBL] [Abstract][Full Text] [Related]
38. 1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry.
Bortin MM; Horowitz MM; Rowlings PA; Rimm AA; Sobocinski KA; Zhang MJ; Gale RP
Bone Marrow Transplant; 1993 Aug; 12(2):97-104. PubMed ID: 8401371
[TBL] [Abstract][Full Text] [Related]
39. [Cyclosporin in allogeneic bone marrow transplantation].
Klingemann HG; Storb R
Internist (Berl); 1985 Sep; 26(9):569-74. PubMed ID: 3905679
[No Abstract] [Full Text] [Related]
40. Allogeneic bone marrow transplantation in the treatment of leukemia: emphasis on graft-vs-host disease and veno-occlusive disease in a Taiwan Chinese series.
Chen YC; Lin KH; Wang CH; Tang JL; Lin MT; Lui LT; Lin DT; Tien HF; Lin KS
Transplant Proc; 1992 Aug; 24(4):1526-8. PubMed ID: 1496646
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
